New Pfizer/BioNTech vaccine variant shows enhanced protection against COVID-19 hospitalization

Study demonstrates that the BNT162b2 SARS-CoV-2 XBB1.5 variant-modified vaccine significantly reduces the risk of COVID-19-related hospitalizations and ambulatory visits, outperforming previous vaccine versions in the face of evolving virus strains.

Hemogenyx gets reprieve as FDA lifts clinical hold on AML CAR-T therapy – Pharmaceutical Technology

Share this article The FDA placed a clinical hold on the trial for HEMO-CAR-T in June, requesting additional information from Hemogenyx. Credit: JHVEPhoto via Shutterstock.

February 9, 2024

Value-Based Care Versus Fee-for-Service: Understanding the Key Differences in Healthcare Models

Ram Krishnan, CEO, Valant Value-based care and fee-for-service are two kinds of healthcare reimbursement models for pricing healthcare services. While the fee-for-service model is more

June 16, 2023

Turning senescent tumor cells into targets for better cancer treatment

Cancer treatments, including chemotherapy, in addition to killing a large number of tumor cells, also result in the generation of senescent tumor cells (also called

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.